Sera Prognostics, Inc. SEC filings SERA

Sera Prognostics, Inc. has 660 filings in SEC EDGAR's recent list, going back to Nov 21, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Sera Prognostics, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material Jun 1, 2026 —
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Apr 23, 2026
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 5, 2025
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 6, 2024
DEFA14A Additional proxy material Apr 25, 2023 —
DEF 14A Proxy statement Apr 25, 2023 Jun 8, 2023
PRE 14A Preliminary proxy statement Apr 14, 2023 Jun 8, 2023
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 3, 2022

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
SERA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Salt Lake City, UT
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1534969
Former names
SERA PROGNOSTICS, INC. (until Nov 4, 2026)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.